Gabapentin

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 68071-3523
  • Package NDC 68071-3523-9
  • Application number ANDA207057
  • SPL ID 2d3f8d53-7482-27fd-e063-6294a90a2171
  • SPL set ID 07871ab8-254b-e3c2-e063-6294a90a29ab
  • UNII 6CW7F3G59X
  • RxCUI 310434

What the source publishes

Labeler
NuCare Pharmaceuticals,Inc.
Active ingredients
Gabapentin
Form
TABLET, COATED
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:68071-3523_2d3f8d53-7482-27fd-e063-6294a90a2171
{
  "name": "Gabapentin",
  "splId": "2d3f8d53-7482-27fd-e063-6294a90a2171",
  "labels": [
    {
      "setId": "07871ab8-254b-e3c2-e063-6294a90a29ab",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=07871ab8-254b-e3c2-e063-6294a90a29ab",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=07871ab8-254b-e3c2-e063-6294a90a29ab"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "NuCare Pharmaceuticals,Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "90 TABLET, COATED in 1 BOTTLE, PLASTIC (68071-3523-9)",
      "package_ndc": "68071-3523-9",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20231012"
    }
  ],
  "productId": "68071-3523_2d3f8d53-7482-27fd-e063-6294a90a2171",
  "useDomain": "unknown",
  "dosageForm": "TABLET, COATED",
  "productNdc": "68071-3523",
  "deaSchedule": null,
  "genericName": "Gabapentin",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "GABAPENTIN",
      "strength": "800 mg/1"
    }
  ],
  "applicationNumber": "ANDA207057",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20211101",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000008486"
    ],
    "upc": [
      "0368071352399"
    ],
    "unii": [
      "6CW7F3G59X"
    ],
    "rxcui": [
      "310434"
    ],
    "spl_set_id": [
      "07871ab8-254b-e3c2-e063-6294a90a29ab"
    ],
    "pharm_class_pe": [
      "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
    ],
    "manufacturer_name": [
      "NuCare Pharmaceuticals,Inc."
    ]
  },
  "listingExpirationDate": "20261231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:68071-3523_2d3f8d53-7482-27fd-e063-6294a90a2171"